Cheng-Cheung Chen
Overview
Explore the profile of Cheng-Cheung Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng Y, Chen C, Liu P, Chen W, Hsu C, Chen C, et al.
Heliyon
. 2025 Mar;
11(4):e42503.
PMID: 40034326
SARS-CoV-2, the virus responsible for COVID-19, triggers the synthesis of full-length genomic RNA (gRNA) and subgenomic RNAs (sgRNAs) in host cells upon infection. Traditional PCR aimed at targeting gRNA to...
2.
Chuang C, Chen C, Chen X, Lee C, Chang Y, Tsai M, et al.
Int J Biol Macromol
. 2025 Feb;
304(Pt 1):140689.
PMID: 39914530
Liposomal vaccines have been developed extensively in recent years, and considerable progress has been made in the prevention of infectious diseases. Quaternary chitosan-coated liposomes were used in the present study....
3.
Liu P, Chang T, Chen X, Cheng C, Huang C, Chen A, et al.
Int J Biol Macromol
. 2024 Nov;
284(Pt 1):137996.
PMID: 39586441
This study introduced a novel antiviral approach by combining three substances with different antiviral mechanisms: N-(2-hydroxy)propyl-3-trimethylammoniumchitosan (HTC), silver nanoparticles (AgNPs), and oseltamivir. First, positively surface-charged AgNPs were prepared using an...
4.
Chen X, Chuang C, Chen C, Lee C, Chin C, Young J, et al.
Colloids Surf B Biointerfaces
. 2024 Jun;
241:114030.
PMID: 38901267
To enhance the cellular uptake of liposomes, we prepared conventional liposomes with targeting molecules and surface-charged liposomes and evaluated their potential as nano-carriers and vaccine adjuvants by comparing their endocytosis...
5.
Chang Y, Hsu M, Chen W, Wu M, Kong W, Lu M, et al.
JCI Insight
. 2024 May;
9(10).
PMID: 38775156
Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at risk of severe COVID-19. Thus, the...
6.
Wang K, Kuan T, Chen Y, Chu Y, Chen J, Chen C, et al.
Biosens Bioelectron
. 2024 Jan;
249:116021.
PMID: 38219466
Flexible laser-scribed graphene (LSG) substrates with gold nanoislands have been developed as biochips for in situ electrochemical (EC) and surface-enhanced Raman scattering (SERS) biodetection (biomolecules and viral proteins). A flexible...
7.
Hsu C, Chen C, Chen W, Liu P, Chang T, Lin M, et al.
Heliyon
. 2023 Dec;
9(11):e22138.
PMID: 38045158
The incidence of zoonotic diseases, such as coronavirus disease 2019 and Ebola virus disease, is increasing worldwide. However, drug and vaccine development for zoonotic diseases has been hampered because the...
8.
Sun C, Chiu C, Wu P, Tsung S, Lee I, Hu C, et al.
Mol Ther
. 2023 Sep;
31(11):3322-3336.
PMID: 37689971
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the emergence of new variants that are resistant to existing vaccines and therapeutic antibodies, has raised the...
9.
Yang M, Chien T, Cheng Y, Hsieh C, Syu W, Wang K, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Jul;
303:123190.
PMID: 37499474
Gold (Au) nano-island arrays were deposited on the glass substrate to fabricate surface-enhanced Raman scattering (SERS) substrates by in-situ thermal evaporation (deposited and annealed samples at the same time). The...
10.
Yeh C, Lee C, Ho Y, Chen S, Chen L, Liu P, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359294
(Background) The coronavirus disease 2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carries high infectivity and mortality. Efficient intervention strategies are urgently needed. Avian immunoglobulin...